This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 1996 Feb 22;334(8):529-30.

doi: 10.1056/NEJM199602223340810.

Management of myeloma with bisphosphonates

PMID: 8559209
DOI: 10.1056/NEJM199602223340810

Editorial

Management of myeloma with bisphosphonates

R Bataille. N Engl J Med. 1996.

. 1996 Feb 22;334(8):529-30.

doi: 10.1056/NEJM199602223340810.

Author

PMID: 8559209
DOI: 10.1056/NEJM199602223340810

No abstract available

PubMed Disclaimer

Comment on

Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma Aredia Study Group.
Berenson JR, Lichtenstein A, Porter L, Dimopoulos MA, Bordoni R, George S, Lipton A, Keller A, Ballester O, Kovacs MJ, Blacklock HA, Bell R, Simeone J, Reitsma DJ, Heffernan M, Seaman J, Knight RD. Berenson JR, et al. N Engl J Med. 1996 Feb 22;334(8):488-93. doi: 10.1056/NEJM199602223340802. N Engl J Med. 1996. PMID: 8559201 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information